Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 736

1.

Hydrogels for biomedical applications from glycol chitosan and PEG diglycidyl ether exhibit pro-angiogenic and antibacterial activity.

Tripodo G, Trapani A, Rosato A, Di Franco C, Tamma R, Trapani G, Ribatti D, Mandracchia D.

Carbohydr Polym. 2018 Oct 15;198:124-130. doi: 10.1016/j.carbpol.2018.06.061. Epub 2018 Jun 18.

PMID:
30092982
2.

[New frontiers of therapy: bibliotherapy.]

Centonze V, Palmieri VO, Addabbo F, Palmiotti GP, Albano MG, Ribatti D, Portincasa P.

Recenti Prog Med. 2018 Jul-Aug;109(7):384-387. doi: 10.1701/2955.29707. Italian.

PMID:
30087501
3.

The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.

Ribatti D, Tamma R.

J Cell Physiol. 2018 Aug 5. doi: 10.1002/jcp.26773. [Epub ahead of print] Review.

PMID:
30078179
4.

New Insights in Anti-Angiogenesis in Multiple Myeloma.

Ribatti D, Vacca A.

Int J Mol Sci. 2018 Jul 12;19(7). pii: E2031. doi: 10.3390/ijms19072031. Review.

5.

The dual role of mast cells in tumor fate.

Ribatti D, Tamma R, Crivellato E.

Cancer Lett. 2018 Oct 1;433:252-258. doi: 10.1016/j.canlet.2018.07.005. Epub 2018 Jul 5.

PMID:
29981810
6.

A revisited concept. Tumors: Wounds that do not heal.

Ribatti D, Tamma R.

Crit Rev Oncol Hematol. 2018 Aug;128:65-69. doi: 10.1016/j.critrevonc.2018.05.016. Epub 2018 Jun 6. Review.

PMID:
29958632
7.

Use of the Stromal Vascular Fraction in Intermediate-Deep Acute Burns: A Case With Its Own Control.

Giudice G, Filoni A, Maggio G, Bonamonte D, Maruccia M, Nacchiero E, Ribatti D, Annese T, Vestita M.

J Burn Care Res. 2017 Dec 4. doi: 10.1093/jbcr/irx017. [Epub ahead of print]

PMID:
29931257
8.
9.

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

Tamma R, Ruggieri S, Annese T, Simone G, Mangia A, Rega S, Zito FA, Nico B, Ribatti D.

Oncotarget. 2018 Apr 27;9(32):22727-22740. doi: 10.18632/oncotarget.25220. eCollection 2018 Apr 27.

10.

The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Sisto M, Lisi S, Ribatti D.

Histochem Cell Biol. 2018 Aug;150(2):133-147. doi: 10.1007/s00418-018-1680-y. Epub 2018 May 23. Review.

PMID:
29789993
11.

Historical overview of lymphangiogenesis.

Ribatti D.

Curr Opin Immunol. 2018 May 19;53:161-166. doi: 10.1016/j.coi.2018.04.027. [Epub ahead of print]

PMID:
29787938
12.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 May 15. doi: 10.1007/s10456-018-9613-x. [Epub ahead of print] Review.

13.

VEGFA and VEGFR2 RNAscope determination in gastric cancer.

Tamma R, Annese T, Ruggieri S, Marzullo A, Nico B, Ribatti D.

J Mol Histol. 2018 May 14. doi: 10.1007/s10735-018-9777-0. [Epub ahead of print]

PMID:
29761299
14.

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

Lamanuzzi A, Saltarella I, Desantis V, Frassanito MA, Leone P, Racanelli V, Nico B, Ribatti D, Ditonno P, Prete M, Solimando AG, Dammacco F, Vacca A, Ria R.

Oncotarget. 2018 Apr 17;9(29):20563-20577. doi: 10.18632/oncotarget.25003. eCollection 2018 Apr 17.

15.

[Alzheimer's disease: an actual planetary health emergency.]

Ribatti D.

Recenti Prog Med. 2018 Apr;109(4):249-253. doi: 10.1701/2896.29197. Italian.

PMID:
29689041
16.

Publisher Correction: Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats.

Sjöqvist S, Jungebluth P, Lim ML, Haag JC, Gustafsson Y, Lemon G, Baiguera S, Burguillos MA, Del Gaudio C, Rodríguez AB, Sotnichenko A, Kublickiene K, Ullman H, Kielstein H, Damberg P, Bianco A, Heuchel R, Zhao Y, Ribatti D, Ibarra C, Joseph B, Taylor DA, Macchiarini P.

Nat Commun. 2018 Apr 10;9:16208. doi: 10.1038/ncomms16208.

17.

The Staining of Mast Cells: A Historical Overview.

Ribatti D.

Int Arch Allergy Immunol. 2018;176(1):55-60. doi: 10.1159/000487538. Epub 2018 Mar 29.

18.

Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.

Desantis V, Frassanito MA, Tamma R, Saltarella I, Di Marzo L, Lamanuzzi A, Solimando AG, Ruggieri S, Annese T, Nico B, Vacca A, Ribatti D.

Ann Hematol. 2018 Jul;97(7):1251-1258. doi: 10.1007/s00277-018-3293-x. Epub 2018 Mar 28.

PMID:
29589107
19.

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.

Rao L, De Veirman K, Giannico D, Saltarella I, Desantis V, Frassanito MA, Solimando AG, Ribatti D, Prete M, Harstrick A, Fiedler U, De Raeve H, Racanelli V, Vanderkerken K, Vacca A.

Oncotarget. 2018 Jan 30;9(17):13366-13381. doi: 10.18632/oncotarget.24351. eCollection 2018 Mar 2.

20.

A new role of mast cells in arteriogenesis.

Ribatti D.

Microvasc Res. 2018 Jul;118:57-60. doi: 10.1016/j.mvr.2018.02.008. Epub 2018 Mar 5. Review.

PMID:
29501537
21.

<em>Recensione</em><BR> Storia dell'AIDS.

Ribatti D.

Recenti Prog Med. 2018 Feb;109(2):153. doi: 10.1701/2865.28916. Italian. No abstract available.

PMID:
29493647
22.

Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.

Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D.

Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Review.

PMID:
29492715
23.

Natalizumab reduces serum pro-angiogenic activity in MS patients.

Iaffaldano P, Ribatti D, Trojano M.

Neurol Sci. 2018 Apr;39(4):725-731. doi: 10.1007/s10072-018-3266-9. Epub 2018 Feb 13.

PMID:
29441483
24.

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Ferretti E, Di Carlo E, Ognio E, Fraternali-Orcioni G, Corcione A, Belmonte B, Ravetti JL, Tripodo C, Ribatti D, Pistoia V.

Oncoimmunology. 2017 Nov 27;7(3):e1397249. doi: 10.1080/2162402X.2017.1397249. eCollection 2018.

PMID:
29399397
25.

An historical note on the cell theory.

Ribatti D.

Exp Cell Res. 2018 Mar 1;364(1):1-4. doi: 10.1016/j.yexcr.2018.01.038. Epub 2018 Jan 31. Review.

PMID:
29391153
26.

Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.

Gaudio F, Tamma R, Ingravallo G, Perrone T, Laddaga FE, De Candia M, Maiorano E, Ribatti D, Specchia G.

Ann Hematol. 2018 Apr;97(4):663-668. doi: 10.1007/s00277-017-3212-6. Epub 2018 Jan 23.

PMID:
29362889
27.

Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Sisto M, Lorusso L, Ingravallo G, Tamma R, Nico B, Ribatti D, Ruggieri S, Lisi S.

J Mol Histol. 2018 Apr;49(2):111-121. doi: 10.1007/s10735-017-9751-2. Epub 2018 Jan 4.

PMID:
29302763
28.

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biologics. 2017 Dec 14;11:123-128. doi: 10.2147/BTT.S143674. eCollection 2017. Review.

29.

The functional anatomy of the cerebrocerebellar circuit: A review and new concepts.

Benagiano V, Rizzi A, Lorusso L, Flace P, Saccia M, Cagiano R, Ribatti D, Roncali L, Ambrosi G.

J Comp Neurol. 2018 Apr 1;526(5):769-789. doi: 10.1002/cne.24361. Epub 2017 Dec 26. Review.

PMID:
29238972
30.

Angiogenesis in adenosquamous cancer of pancreas.

Silvestris N, Danza K, Longo V, Brunetti O, Fucci L, Argentiero A, Calabrese A, Cataldo I, Tamma R, Ribatti D, Tommasi S.

Oncotarget. 2017 Sep 27;8(56):95773-95779. doi: 10.18632/oncotarget.21319. eCollection 2017 Nov 10.

31.

A historical perspective on milestones in multiple myeloma research.

Ribatti D.

Eur J Haematol. 2018 Mar;100(3):221-228. doi: 10.1111/ejh.13003. Epub 2017 Dec 27. Review.

PMID:
29194778
32.

[Reflections on the death of my father.]

Ribatti D.

Recenti Prog Med. 2017 Nov;108(11):481-484. doi: 10.1701/2812.28443. Italian.

PMID:
29149165
33.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

34.

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?

Puxeddu I, Pratesi F, Ribatti D, Migliorini P.

Mediators Inflamm. 2017;2017:4123694. doi: 10.1155/2017/4123694. Epub 2017 Sep 5. Review.

35.

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biomed Res Int. 2017;2017:5312813. doi: 10.1155/2017/5312813. Epub 2017 Jul 19. Review.

36.

Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biomed Res Int. 2017;2017:5345673. doi: 10.1155/2017/5345673. Epub 2017 Jul 16. Review.

37.

Historical overview on the morphological characterization of large granular lymphocytes/natural killer cells.

Ribatti D.

Immunol Lett. 2017 Oct;190:58-63. doi: 10.1016/j.imlet.2017.07.014. Epub 2017 Jul 27. Review.

PMID:
28757130
38.

Spatial distribution of mast cells and macrophages around tumor glands in human breast ductal carcinoma.

Tamma R, Guidolin D, Annese T, Tortorella C, Ruggieri S, Rega S, Zito FA, Nico B, Ribatti D.

Exp Cell Res. 2017 Oct 1;359(1):179-184. doi: 10.1016/j.yexcr.2017.07.033. Epub 2017 Jul 27.

PMID:
28756894
39.

Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases.

Girolamo F, Coppola C, Ribatti D.

Brain Behav Immun. 2017 Oct;65:68-89. doi: 10.1016/j.bbi.2017.06.017. Epub 2017 Jul 1. Review.

PMID:
28676349
40.

Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.

Sisto M, Lorusso L, Ingravallo G, Nico B, Ribatti D, Ruggieri S, Lofrumento DD, Lisi S.

Autoimmunity. 2017 Jun;50(4):202-210. doi: 10.1080/08916934.2017.1341495. Epub 2017 Jun 24.

PMID:
28648105
41.

A revisited concept: Contact inhibition of growth. From cell biology to malignancy.

Ribatti D.

Exp Cell Res. 2017 Oct 1;359(1):17-19. doi: 10.1016/j.yexcr.2017.06.012. Epub 2017 Jun 20. Review.

PMID:
28642051
42.

The discovery of plasma cells: An historical note.

Ribatti D.

Immunol Lett. 2017 Aug;188:64-67. doi: 10.1016/j.imlet.2017.06.006. Epub 2017 Jun 17. Review.

PMID:
28633925
43.

Scholars and scientists in the history of the lymphatic system.

Natale G, Bocci G, Ribatti D.

J Anat. 2017 Sep;231(3):417-429. doi: 10.1111/joa.12644. Epub 2017 Jun 14. Review.

PMID:
28614587
44.

Mast cells in breast cancer angiogenesis.

Cimpean AM, Tamma R, Ruggieri S, Nico B, Toma A, Ribatti D.

Crit Rev Oncol Hematol. 2017 Jul;115:23-26. doi: 10.1016/j.critrevonc.2017.04.009. Epub 2017 Apr 27. Review.

PMID:
28602166
45.

Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.

Dawoody Nejad L, Biglari A, Annese T, Ribatti D.

Oncol Lett. 2017 Jun;13(6):4475-4480. doi: 10.3892/ol.2017.5960. Epub 2017 Mar 31.

46.

Angiogenesis versus arteriogenesis.

Rizzi A, Benagiano V, Ribatti D.

Rom J Morphol Embryol. 2017;58(1):15-19. Review.

47.

Sales for anti-angiogenic drugs.

Ribatti D.

Oncotarget. 2017 Jun 13;8(24):38080-38081. doi: 10.18632/oncotarget.17373. No abstract available.

48.

Triple negative breast cancer: the kiss of death.

Jitariu AA, Cîmpean AM, Ribatti D, Raica M.

Oncotarget. 2017 Jul 11;8(28):46652-46662. doi: 10.18632/oncotarget.16938. Review.

49.

Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.

Ruggieri S, Tamma R, Resta N, Albano F, Coccaro N, Loconte D, Annese T, Errede M, Specchia G, Senetta R, Cassoni P, Ribatti D, Nico B.

Oncotarget. 2017 May 9;8(19):31254-31269. doi: 10.18632/oncotarget.16115.

50.

Natural polymeric microspheres for modulated drug delivery.

Del Gaudio C, Crognale V, Serino G, Galloni P, Audenino A, Ribatti D, Morbiducci U.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:408-417. doi: 10.1016/j.msec.2017.02.051. Epub 2017 Feb 16.

PMID:
28415479

Supplemental Content

Loading ...
Support Center